1-3 of 3
Mark W. Kunkel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB_A21: NCI60 HTS384: The next phase of the NCI60 screen

Beverly A Teicher, Mark W Kunkel, Joel Morris, Ronald C Taylor, Thomas S Dexheimer, Nathan P Coussens, James H Doroshow
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): LB_A21.
https://doi.org/10.1158/1535-7163.TARG-23-LB_A21
Published: 01 December 2023
View article titled, Abstract LB_A21: NCI60 HTS384: The next phase of the NCI60 screen
Journal Articles

Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource

Joel Morris, Mark W. Kunkel, Stephen L. White, Donn G. Wishka, Omar D. Lopez, Lori Bowles, Penny Sellers Brady, Patricia Ramsey, Julie Grams, Tiffany Rohrer, Karen Martin, Thomas S. Dexheimer, Nathan P. Coussens, David Evans, Prabhakar Risbood, Dmitriy Sonkin, John D. Williams, Eric C. Polley, Jerry M. Collins, James H. Doroshow, Beverly A. Teicher
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (11): 1270–1279.
https://doi.org/10.1158/1535-7163.MCT-23-0267
Published: 01 November 2023
View article titled, Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource
Open the PDF for Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems–based Resource in another window
Includes: Supplementary data
Journal Articles

F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

Joel Morris, Donn G. Wishka, Omar D. Lopez, Vladimir Rudchenko, Guangfei Huang, Sierra N. Hoffman, Suzanne Borgel, Kyle Georgius, John Carter, Howard Stotler, Mark W. Kunkel, Jerry M. Collins, Melinda G. Hollingshead, Beverly A. Teicher
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2021) 20 (4): 625–631.
https://doi.org/10.1158/1535-7163.MCT-20-0738
Published: 01 April 2021
View article titled, F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd
Open the PDF for F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd in another window
Includes: Supplementary data